🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎙🚨 Hey RadOnc! OncoAlert Curious 🤔about the biggest breakthroughs in ☢️oncology this year? 💥 We’ve rounded up the top 10 clinical trials of 2024 that are reshaping how we treat cancer. From SBRT to immunotherapy combos, there’s something for everyone. Let’s dive in! 🧵👇

📢We say"good bye"to 2024 proud to be part of an International Team🇧🇷🇨🇦🇮🇹🇺🇲that contributed to the first systematic review & meta-analysis of #SAbR in LA-NSCLC! 💪🏻There is room for #SAbR in LA-NSCLC! 🔝Very intriguing topic Excellent work by a Dream Team💯 doi.org/10.1016/j.rado…

🚨Breaking Barriers in Global Oncology❗️OncoAlert The Lancet Oncology Dr. Fabio Moraes Andre G, MD, Rad Onc ⚽️ 🇮🇹 🇨🇦 We proudly introduce the Linear Accelerator Shortage Index (LSI)—a groundbreaking tool designed to bring hope and healing to regions where ☢️ is most needed❗️❗️ 🔬Methods

Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study - The Lancet Oncology thelancet.com/journals/lanon…

This study analyzes global disparities in access to radiotherapy and proposes tailored recommendations, taking into account the costs involved to ensure adequate service provision in over 180 countries. Congrats: Dr. Fabio Moraes Gustavo Dr. Gustavo Nader Marta, MD, PhD @HannaRadOnc Ajay Aggarwal

Radiotherapy is a cornerstone of cancer care, yet millions globally remain underserved due to equipment shortages, workforce gaps, and underinvestment.

As researchers and practitioners, we know that there are no shortcuts in solving global health challenges. Behind impactful work lies years of collaboration, critical thinking, and methodological rigor.

💡 Inspired by our findings, I am committed to empowering others to think critically and execute high-impact research faster and smarter. Together, we can amplify efforts to close the gap in access and outcomes worldwide.

Let’s keep pushing boundaries in oncology and beyond—because every patient deserves equitable care. #GlobalHealth #Radiotherapy #OncologyResearch #HighImpactResearch #HealthEquity

Global linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study out on Lancet Oncology buff.ly/3PHWdXy This study utilized the Linear Accelerator Shortage Index (LSI) to assess global disparities in the

Every time they approve a drug based on non-survival endpoint, they give us some excuse. I have collected those excuses. There are seven of them. In this new column in Medscape , I and Dr. Sharon Batt, a cancer survivor and regulatory science expert, list these seven arguments

📜 In The Lancet Reg Health-Americas, we draw attention to the #political #determinants of #cancer #health in the context of national cancer control plans 🙏 #patient #advocate Kara Magsanoc-Alikpala & Drs Dr. Fabio Moraes Jonas Willmann, MD Fred Ting Erin Feliciano, MD, MBA 🔗 sciencedirect.com/science/articl…

Donald J. Trump Well done, comrade!

🔔📣📢 RADIOSA full paper is finally out! Read our publication now online on The Lancet Oncology! Randomised trial in the metachronous oligomets hormone-sensitive PCa setting reporting improved clinical PFS with the combination of SBRT and a short course of ADT!

Drew Moghanaki Jill Feldman GO2 for Lung Cancer LUNGevity Foundation LungCancerAmerica ACS National Lung Cancer Roundtable We welcome any drug that can further revolutionize prognosis of IV stage NSCLC!And whatever the drug,there is #SAbR -the best lifesaver- ready to help with its efficacy and safety!All to maintain a drug that globally works by increasing OS and above all the psycho-physical QoL!

Live from #ESTRO2025: ESTRO President Matthias Guckenberger highlights key challenges to sustainable innovation in radiation therapy — from regulatory hurdles and funding gaps to staffing and perception issues. A call to action for global RT advancement. #RadOnc #HealthInnovation

I am pleased to share the link for the final publication of the PBS trial conducted at JCC and WFCC. Congratulations to the entire team, and thank you to the patients. McMaster University onlinelibrary.wiley.com/doi/10.1002/pr…

I’m happy to share that I am now officially listed as a Clinical Assistant Professor at the University of British Columbia! It’s a privilege to be part of such a respected institution. surgery.med.ubc.ca/andre-gouveia-…

"Jumento pode estar em extinção no Brasil" -Sim, estão todos no PSG.

Opinião - Giovanni Guido Cerri e Fabio Ynoe de Moraes: Inovação em saúde: os caminhos da evolução www1.folha.uol.com.br/opiniao/2025/0…